CJ Bioscience Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 10, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	53,568	121,770	131,831	147,076	170,481	286,048
Market Cap Growth	-56.66%	-7.63%	-10.37%	-13.73%	-40.40%	43.54%
Enterprise Value	20,050	74,179	98,118	116,989	139,502	291,080
Last Close Price	4100.00	9320.00	10090.00	16140.00	24887.51	41793.85
PS Ratio	15.04	32.98	38.03	26.38	41.84	65.56
PB Ratio	1.11	2.27	1.70	2.06	3.43	3.26
P/TBV Ratio	1.47	2.91	2.02	2.49	3.51	3.26
EV/Sales Ratio	5.63	20.09	28.30	20.98	34.24	66.72
Debt / Equity Ratio	0.22	0.19	0.12	0.12	0.58	0.27
Net Debt / Equity Ratio	-0.70	-0.75	-0.85	-0.78	-0.41	-0.64
Net Debt / EBITDA Ratio	1.71	1.95	2.20	2.07	0.69	6.58
Net Debt / FCF Ratio	1.69	1.73	2.34	1.86	0.81	5.98
Asset Turnover	0.05	0.04	0.04	0.06	0.04	0.05
Inventory Turnover	13.88	19.50	22.21	32.50	24.90	10.67
Quick Ratio	3.46	3.55	4.10	4.38	1.43	3.39
Current Ratio	3.54	3.61	4.14	4.43	1.46	3.42
Return on Equity (ROE)	-38.42%	-36.54%	-44.00%	-37.82%	-50.78%	-31.51%
Return on Assets (ROA)	-19.14%	-18.02%	-22.44%	-21.95%	-20.00%	-6.66%
Return on Capital Employed (ROCE)	-45.20%	-42.90%	-42.20%	-42.00%	-58.90%	-10.90%
Earnings Yield	-42.94%	-19.71%	-24.91%	-15.58%	-20.48%	-6.74%
FCF Yield	-37.05%	-19.24%	-21.34%	-20.28%	-14.73%	-3.28%
Buyback Yield / Dilution	-27.31%	-40.89%	-30.92%	-20.52%	-38.23%	-10.14%